Company / Current Assets
IDEAYA Biosciences, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$666.7M
FY2025
5-year range
$251.0M / $689.7M
FY2021-FY2025
Trend
-3.3%
vs FY2024
Sector context
#87 of 213
Health Care
What the data says
At $667M, IDEAYA Biosciences, Inc.'s current assets ranks #87 of 213 in the Health Care sector. Current Assets has fluctuated over the past 8 years, ranging from $91M in FY2018 to $690M in FY2024.
Based on SEC 10-K filings.
$667M in FY2025 with a 5-year CAGR of +18.2%.
Improved from $533M to $667M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +18.2%
- 10-Year CAGR
- -
Sector benchmark
#87 of 213 in Health CareTop 41% of 213This company $666.7M Sector average $2.5B
▼
-73.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.2%, indicating consistent growth.
- In FY2025, current assets decreased 3.3% year-over-year.
- Ranks #87 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $666.7M | -3.3% |
| FY2024 | $689.7M | +29.5% |
| FY2023 | $532.6M | +43.8% |
| FY2022 | $370.5M | +47.6% |
| FY2021 | $251.0M | -13.0% |
| FY2020 | $288.6M | +183.9% |
| FY2019 | $101.7M | +12.1% |
| FY2018 | $90.7M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026